 China Biologic Products Holdings, Inc. NASDAQ: CBPO China Biologic or the Company, a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its first quarter 2020 financial results on Wednesday, May 20, 2020 after the market closes. 